Engwegen JY - Search Results

1

Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancer.

Engwegen JY, Alberts M, Knol JC, Jimenez CR, Depla AC, Tuynman H, van Heukelem HA, Snel P, Smits ME, Cats A, Schellens JH, Beijnen JH. Engwegen JY, et al. Proteomics Clin Appl. 2008 Jun;2(6):936-45. doi: 10.1002/prca.200780068. Proteomics Clin Appl. 2008. PMID: 21136891 No abstract available.

2

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.

Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH, Beijnen JH. Engwegen JY, et al. World J Gastroenterol. 2006 Mar 14;12(10):1536-44. doi: 10.3748/wjg.v12.i10.1536. World J Gastroenterol. 2006. PMID: 16570345 Free PMC article.

3

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.

Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Engwegen JY, et al. Trends Pharmacol Sci. 2006 May;27(5):251-9. doi: 10.1016/j.tips.2006.03.003. Epub 2006 Apr 4. Trends Pharmacol Sci. 2006. PMID: 16600386 Review.

4

Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations.

Engwegen JY, Mehra N, Haanen JB, Bonfrer JM, Schellens JH, Voest EE, Beijnen JH. Engwegen JY, et al. Lab Invest. 2007 Feb;87(2):161-72. doi: 10.1038/labinvest.3700503. Lab Invest. 2007. PMID: 17318195 Free article.

5

Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling.

Gast MC, Engwegen JY, Schellens JH, Beijnen JH. Gast MC, et al. Among authors: engwegen jy. BMC Med Genomics. 2008 Jan 31;1:4. doi: 10.1186/1755-8794-1-4. BMC Med Genomics. 2008. PMID: 18237384 Free PMC article.

6

Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk.

Engwegen JY, Depla AC, Smits ME, Cats A, Tuynman H, van Heukelem HA, Snel P, Meuleman W, Wessels LF, Schellens JH, Beijnen JH. Engwegen JY, et al. Biomark Insights. 2008 Jul 2;3:375-385. doi: 10.4137/bmi.s790. Biomark Insights. 2008. PMID: 19578519 Free PMC article.

7

Identification of two new serum protein profiles for renal cell carcinoma.

Engwegen JY, Mehra N, Haanen JB, Schellens JH, Voest EE, Beijnen JH. Engwegen JY, et al. Oncol Rep. 2009 Aug;22(2):401-8. Oncol Rep. 2009. PMID: 19578783

8

Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.

Helgason HH, Engwegen JY, Zapatka M, Cats A, Boot H, Beijnen JH, Schellens JH. Helgason HH, et al. Among authors: engwegen jy. Oncol Lett. 2010 Mar;1(2):327-333. doi: 10.3892/ol_00000058. Epub 2010 Mar 1. Oncol Lett. 2010. PMID: 22966303 Free PMC article.

9

Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data.

Meuleman W, Engwegen JY, Gast MC, Beijnen JH, Reinders MJ, Wessels LF. Meuleman W, et al. Among authors: engwegen jy. BMC Bioinformatics. 2008 Feb 7;9:88. doi: 10.1186/1471-2105-9-88. BMC Bioinformatics. 2008. PMID: 18257918 Free PMC article.

10

Evaluation of human neutrophil peptide-1, -2 and -3 as serum markers for colorectal cancer.

van den Broek I, Sparidans RW, Engwegen JY, Cats A, Depla AC, Schellens JH, Beijnen JH. van den Broek I, et al. Among authors: engwegen jy. Cancer Biomark. 2010;7(2):109-15. doi: 10.3233/CBM-2010-0153. Cancer Biomark. 2010. PMID: 21178269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters